Etcembly’s vision is to decode immune repertoires for health and disease.
The TCR repertoire holds the answers to therapeutics and biomarker information, and Etcembly is assembling the world’s largest health and disease immune database, to revolutionise immunotherapy and personalised therapeutics across all patient groups, globally.
We are pushing the frontiers to explore the intersection between immunology and machine learning.
Company Details
- Employees
- 32
- Founded
- -
- Address
- Fermi Avenue, Harwell Campus,england Ox11 0,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.etcembly.com/
- Keywords
- is now a simple search.
- HQ
- Harwell Campus, England
Etcembly Ltd Questions
Etcembly Ltd's website is https://www.etcembly.com/
Etcembly Ltd's LinkedIn profile is https://uk.linkedin.com/company/etcembly-ltd
Etcembly Ltd has
32 employees.
View email and phone details for 32
employees at Etcembly Ltd.
Etcembly Ltd's industry is
Biotechnology Research
Etcembly Ltd's top competitors are
Immunocore,
T-Cypher Bio,
Enara Bio,
Pharmenable Therapeutics,
Adaptimmune,
Accession Therapeutics Limited,
Ochre Bio,
Sixfold Bioscience,
Turing Biosystems,
Synaptixbio Ltd..
Etcembly Ltd's categories are Biotechnology Research
Etcembly Ltd's founding year is 2020
